National Cancer Center Partnership Expected to Advance Cancer Research at YSPH, Yale
A new partnership with the National Cancer Center of China will provide opportunities for collaborative research, clinical trials and workforce training at the Yale School of Public Health, Yale Cancer Center and Yale Institute for Global Health.
New initiative will fund innovative solutions in health care
Globalization, changing lifestyles, and urbanization have a significant impact on the health of communities in India and around the world. To address these growing health and social disparities, the Yale Institute for Global Health (YIGH) has partnered with The CoWrks Foundry and the RMZ Foundation to launch the Sustainable Health Initiative (SHI).
Yale doctor helps highlight for worldwide focus on ‘silent killers’
In today’s world, non-communicable diseases (NCDs) such as cancers, heart and respiratory disease, diabetes, and Alzheimer’s — to name just a few — have quietly emerged as a pandemic of silent killers to collectively become the leading cause of death worldwide. Overall according to the World Health Organization (WHO), NCDs are responsible for more than 38 million deaths a year — more than all other causes combined.
Vaccine Expert Named First Director of Yale Institute for Global Health
Saad B. Omer, MBBS, MPH, PhD, has been named the inaugural director of the Yale Institute for Global Health (YIGH). Omer is currently the William H. Foege Professor of Global Health, Epidemiology, and Pediatrics at Emory University’s Schools of Public Health and Medicine.
Asking the Right Questions About Cannabis Legalization
Tony George, MD, HS '96, an addiction specialist at the University of Toronto, believes that Canada has not prepared for legalization and its consequences. He argues that more research on the effects—positive and negative—of smoking pot is needed, as well as increased access to treatment for those who suffer from cannabis use disorder.
Improving the World’s Largest Health System—Scholars Convene at YSPH to Plan for Future
Some 200 researchers and health leaders gathered at Yale University for the second biennial conference of the China Health Policy and Management Society (CHPAMS), focusing on the Healthy China 2030 national blueprint for the health of the 1.3 billion Chinese.
Dyslexia gene variants tied to consonant use across populations
In a new study of languages spoken in 43 different populations worldwide, Yale School of Medicine researchers and their colleagues identified variants of a dyslexia gene that correlate with consonant use, establishing a role for genetics in language differences between populations.
A Zika Vaccine Could Virtually Eliminate Prenatal Infections
A Zika vaccine could have a substantial effect on mitigating and preventing future Zika virus outbreaks. Through a combination of direct protection and indirect reduction of transmissions, virtual elimination is achievable, even with imperfect vaccine efficacy and coverage, a new Yale School of Public Health study finds.
New Global Health Institute announced at Yale
The new Yale Institute for Global Health (YIGH), approved by the Yale Corporation on Dec. 8, further advances President Salovey’s goal for the university to have a greater impact on complex international issues. Led by the Schools of Medicine, Nursing, and Public Health, YIGH is a university-wide effort to address global health issues.
Zika-related nerve damage caused by immune response to the virus
The immune system’s response to the Zika virus, rather than the virus itself, may be responsible for nerve-related complications of infection, according to a Yale study. This insight could lead to new ways of treating patients with Zika-related complications, such as Guillain-Barré syndrome, the researchers said.
China’s out of control ‘silent killer’ affects one-third of adults
More than one-third of adults in China have high blood pressure — often dubbed the “silent killer” for its lack of symptoms — but only about one in 20 have the condition under control. These findings are published Oct. 25 in the Lancet’s special issue on China by researchers at Yale and the Chinese National Center for Cardiovascular Disease.
Immunobiologist Kellie Jurado receives Women in Science Fellowship
Kellie Ann Jurado, a postdoctoral fellow in immunobiology at Yale School of Medicine (YSM), is the recipient of a L’Oreal For Women in Science Fellowship by L'Oréal USA. The fellowship honors female scientists at a critical stage in their careers with $60,000 grants to advance their postdoctoral research.
Yale medical faculty awarded two grants to support health system in Liberia
Faculty at the Yale School of Medicine have been awarded two grants by the World Bank and the U.S. Health Resources and Services Administration (HRSA) to support and strengthen medical education and health management in Liberia.
Cutbacks in Foreign Aid for HIV Treatment Would Cause Great Harm, Generate Few Savings
Proposed reductions in U.S. foreign aid would have a devastating impact on HIV treatment and prevention programs in countries receiving such aid, an international team of investigators reports. In their paper published online in Annals of Internal Medicine, the team led by researchers at Massachusetts General Hospital (MGH) and the Yale School of Public Health describes how a 33 percent cutback in funds earmarked for HIV/AIDS prevention, treatment and research in recent budget proposals would only save $900 per year of life lost in the countries of South Africa and Côte d’Ivoire.